questionsmedicales.fr
Facteurs biologiques
Pigments biologiques
Pigments biliaires
Bilirubine
Bilirubine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Bilirubine
Analyse sanguine
Tests de laboratoire
Fonction hépatique
Maladies hépatiques
Obstruction biliaire
Symptômes
5
Hyperbilirubinémie
Jaunisse
Maladies hépatiques
Symptômes
Prévention
5
Ictère néonatal
Prévention
Examens médicaux
Fonction hépatique
Maladies hépatiques
Prévention
Alimentation
Santé du foie
Traitements
5
Hyperbilirubinémie
Traitement
Transfusions sanguines
Anémie hémolytique
Corticostéroïdes
Bilirubine
Photothérapie
Ictère néonatal
Chirurgie
Obstruction biliaire
Complications
5
Complications
Lésions hépatiques
Hyperbilirubinémie
Dommages cérébraux
Obstruction biliaire
Infections
Grossesse
Hyperbilirubinémie
Cirrhose
Insuffisance hépatique
Facteurs de risque
5
Facteurs de risque
Maladies hépatiques
Alcoolisme
Hyperbilirubinémie
Infections virales
Hépatite
Surpoids
Maladies hépatiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Bilirubine : Questions médicales les plus fréquentes",
"headline": "Bilirubine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Bilirubine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2026-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Bilirubine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pigments biliaires",
"url": "https://questionsmedicales.fr/mesh/D001654",
"about": {
"@type": "MedicalCondition",
"name": "Pigments biliaires",
"code": {
"@type": "MedicalCode",
"code": "D001654",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.193"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Biliverdine",
"alternateName": "Biliverdine",
"url": "https://questionsmedicales.fr/mesh/D001664",
"about": {
"@type": "MedicalCondition",
"name": "Biliverdine",
"code": {
"@type": "MedicalCode",
"code": "D001664",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.193.184.200"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Bilirubine",
"alternateName": "Bilirubin",
"code": {
"@type": "MedicalCode",
"code": "D001663",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Claudio Tiribelli",
"url": "https://questionsmedicales.fr/author/Claudio%20Tiribelli",
"affiliation": {
"@type": "Organization",
"name": "The Liver-Brain Unit \"Rita-Moretti\", Fondazione Italiana Fegato-Onlus, Bldg. Q, AREA Science Park, ss14, Km 163.5, Basovizza, 34149 Trieste, Italy."
}
},
{
"@type": "Person",
"name": "Libor Vítek",
"url": "https://questionsmedicales.fr/author/Libor%20V%C3%ADtek",
"affiliation": {
"@type": "Organization",
"name": "4th Department of Internal Medicine and Institute of Medical Biochemistry and Laboratory Diagnostics, General Faculty Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic."
}
},
{
"@type": "Person",
"name": "Silvia Gazzin",
"url": "https://questionsmedicales.fr/author/Silvia%20Gazzin",
"affiliation": {
"@type": "Organization",
"name": "The Liver-Brain Unit \"Rita-Moretti\", Fondazione Italiana Fegato-Onlus, Bldg. Q, AREA Science Park, ss14, Km 163.5, Basovizza, 34149 Trieste, Italy."
}
},
{
"@type": "Person",
"name": "Sri Jayanti",
"url": "https://questionsmedicales.fr/author/Sri%20Jayanti",
"affiliation": {
"@type": "Organization",
"name": "The Liver-Brain Unit \"Rita-Moretti\", Fondazione Italiana Fegato-Onlus, Bldg. Q, AREA Science Park, ss14, Km 163.5, Basovizza, 34149 Trieste, Italy."
}
},
{
"@type": "Person",
"name": "Kosuke Koyano",
"url": "https://questionsmedicales.fr/author/Kosuke%20Koyano",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Bone cement as a local antibiotic carrier].",
"datePublished": "2023-10-13",
"url": "https://questionsmedicales.fr/article/37831092",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00132-023-04447-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Processing properties and viscosities of PMMA bone cements].",
"datePublished": "2023-10-30",
"url": "https://questionsmedicales.fr/article/37902859",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00132-023-04450-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Chemical and physical properties of PMMA bone cements].",
"datePublished": "2023-10-13",
"url": "https://questionsmedicales.fr/article/37831091",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00132-023-04445-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bone cement implantation syndrome: the role of echocardiography and multidisciplinarity.",
"datePublished": "2024-10-01",
"url": "https://questionsmedicales.fr/article/39353676",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2024-261500"
}
},
{
"@type": "ScholarlyArticle",
"name": "Modification of polymethylmethacrylate bone cement with halloysite clay nanotubes.",
"datePublished": "2024-08-04",
"url": "https://questionsmedicales.fr/article/39098928",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12903-024-04600-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Pigments biologiques",
"item": "https://questionsmedicales.fr/mesh/D010860"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pigments biliaires",
"item": "https://questionsmedicales.fr/mesh/D001654"
},
{
"@type": "ListItem",
"position": 5,
"name": "Bilirubine",
"item": "https://questionsmedicales.fr/mesh/D001663"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Bilirubine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Bilirubine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-06-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Bilirubine",
"description": "Comment mesurer le taux de bilirubine ?\nQuels tests diagnostiques sont utilisés ?\nQu'indique un taux élevé de bilirubine ?\nQuelle est la différence entre bilirubine directe et indirecte ?\nQuels symptômes peuvent nécessiter un test de bilirubine ?",
"url": "https://questionsmedicales.fr/mesh/D001663?mesh_terms=Bone+Cements#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Bilirubine",
"description": "Quels sont les symptômes d'une hyperbilirubinémie ?\nLa bilirubine affecte-t-elle la peau ?\nQuels signes indiquent une maladie hépatique ?\nLa bilirubine peut-elle causer des démangeaisons ?\nComment la bilirubine affecte-t-elle l'urine ?",
"url": "https://questionsmedicales.fr/mesh/D001663?mesh_terms=Bone+Cements#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Bilirubine",
"description": "Comment prévenir l'ictère néonatal ?\nQuels examens réguliers sont recommandés ?\nComment éviter les maladies hépatiques ?\nLes vaccinations sont-elles importantes ?\nComment une alimentation saine aide-t-elle ?",
"url": "https://questionsmedicales.fr/mesh/D001663?mesh_terms=Bone+Cements#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Bilirubine",
"description": "Comment traiter une hyperbilirubinémie ?\nLes transfusions sanguines sont-elles nécessaires ?\nQuels médicaments peuvent réduire la bilirubine ?\nLa photothérapie est-elle efficace ?\nQuand envisager une chirurgie pour la bilirubine ?",
"url": "https://questionsmedicales.fr/mesh/D001663?mesh_terms=Bone+Cements#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Bilirubine",
"description": "Quelles complications peuvent survenir avec une bilirubine élevée ?\nL'hyperbilirubinémie peut-elle causer des dommages cérébraux ?\nQuels sont les risques d'une obstruction biliaire ?\nComment l'hyperbilirubinémie affecte-t-elle la grossesse ?\nQuelles sont les conséquences d'une maladie hépatique avancée ?",
"url": "https://questionsmedicales.fr/mesh/D001663?mesh_terms=Bone+Cements#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Bilirubine",
"description": "Quels facteurs augmentent le risque d'hyperbilirubinémie ?\nL'alcoolisme est-il un facteur de risque ?\nLes infections virales influencent-elles la bilirubine ?\nLe surpoids est-il un facteur de risque ?\nLes médicaments peuvent-ils affecter la bilirubine ?",
"url": "https://questionsmedicales.fr/mesh/D001663?mesh_terms=Bone+Cements#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le taux de bilirubine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le taux de bilirubine est mesuré par une analyse sanguine."
}
},
{
"@type": "Question",
"name": "Quels tests diagnostiques sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la bilirubine totale et directe, ainsi que des tests hépatiques."
}
},
{
"@type": "Question",
"name": "Qu'indique un taux élevé de bilirubine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux élevé peut indiquer une maladie hépatique, une obstruction biliaire ou une anémie."
}
},
{
"@type": "Question",
"name": "Quelle est la différence entre bilirubine directe et indirecte ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La bilirubine directe est soluble dans l'eau, tandis que l'indirecte ne l'est pas."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent nécessiter un test de bilirubine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme jaunisse, fatigue ou douleurs abdominales peuvent nécessiter un test."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une hyperbilirubinémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent jaunisse, urine foncée, selles claires et démangeaisons."
}
},
{
"@type": "Question",
"name": "La bilirubine affecte-t-elle la peau ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un excès de bilirubine peut provoquer un jaunissement de la peau et des yeux."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une maladie hépatique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la fatigue, l'ictère et des douleurs abdominales peuvent indiquer une maladie hépatique."
}
},
{
"@type": "Question",
"name": "La bilirubine peut-elle causer des démangeaisons ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une accumulation de bilirubine peut provoquer des démangeaisons cutanées."
}
},
{
"@type": "Question",
"name": "Comment la bilirubine affecte-t-elle l'urine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux élevé de bilirubine peut rendre l'urine foncée, semblable à celle du thé."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'ictère néonatal ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ictère néonatal peut être prévenu par une surveillance attentive des nouveau-nés et une alimentation adéquate."
}
},
{
"@type": "Question",
"name": "Quels examens réguliers sont recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers de la fonction hépatique sont recommandés pour détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Comment éviter les maladies hépatiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'alcool, maintenir un poids santé et se faire vacciner contre l'hépatite aide à prévenir les maladies hépatiques."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations contre l'hépatite A et B sont cruciales pour prévenir les infections hépatiques."
}
},
{
"@type": "Question",
"name": "Comment une alimentation saine aide-t-elle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée aide à maintenir la santé du foie et à prévenir l'accumulation de bilirubine."
}
},
{
"@type": "Question",
"name": "Comment traiter une hyperbilirubinémie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, comme des médicaments ou une intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans certains cas d'anémie hémolytique, des transfusions peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent réduire la bilirubine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les corticostéroïdes peuvent être utilisés pour traiter certaines conditions."
}
},
{
"@type": "Question",
"name": "La photothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la photothérapie est souvent utilisée pour traiter l'ictère néonatal en réduisant la bilirubine."
}
},
{
"@type": "Question",
"name": "Quand envisager une chirurgie pour la bilirubine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie peut être envisagée en cas d'obstruction biliaire ou de maladies hépatiques graves."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une bilirubine élevée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des lésions hépatiques, des troubles neurologiques et des infections."
}
},
{
"@type": "Question",
"name": "L'hyperbilirubinémie peut-elle causer des dommages cérébraux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperbilirubinémie sévère peut entraîner des dommages cérébraux, surtout chez les nouveau-nés."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une obstruction biliaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des infections, des douleurs abdominales et des lésions hépatiques."
}
},
{
"@type": "Question",
"name": "Comment l'hyperbilirubinémie affecte-t-elle la grossesse ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des complications pour la mère et le fœtus, nécessitant une surveillance étroite."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une maladie hépatique avancée ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences incluent la cirrhose, le cancer du foie et l'insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'hyperbilirubinémie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies hépatiques, des infections et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'alcoolisme est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'alcoolisme peut endommager le foie et augmenter le risque d'hyperbilirubinémie."
}
},
{
"@type": "Question",
"name": "Les infections virales influencent-elles la bilirubine ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections comme l'hépatite peuvent augmenter les niveaux de bilirubine."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids peut contribuer à des maladies hépatiques et à une hyperbilirubinémie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils affecter la bilirubine ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec le métabolisme de la bilirubine et augmenter ses niveaux."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/04/2026
Contenu vérifié selon les dernières recommandations médicales
7 publications dans cette catégorie
Affiliations :
The Liver-Brain Unit "Rita-Moretti", Fondazione Italiana Fegato-Onlus, Bldg. Q, AREA Science Park, ss14, Km 163.5, Basovizza, 34149 Trieste, Italy.
4 publications dans cette catégorie
Affiliations :
4th Department of Internal Medicine and Institute of Medical Biochemistry and Laboratory Diagnostics, General Faculty Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Publications dans "Bilirubine" :
4 publications dans cette catégorie
Affiliations :
The Liver-Brain Unit "Rita-Moretti", Fondazione Italiana Fegato-Onlus, Bldg. Q, AREA Science Park, ss14, Km 163.5, Basovizza, 34149 Trieste, Italy.
Publications dans "Bilirubine" :
3 publications dans cette catégorie
Affiliations :
The Liver-Brain Unit "Rita-Moretti", Fondazione Italiana Fegato-Onlus, Bldg. Q, AREA Science Park, ss14, Km 163.5, Basovizza, 34149 Trieste, Italy.
Faculty of Medicine, University of Hasanuddin, Makassar 90245, Indonesia.
Molecular Biomedicine Ph.D. Program, Department of Life Sciences, University of Trieste, 34127 Trieste, Italy.
Publications dans "Bilirubine" :
3 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Publications dans "Bilirubine" :
3 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Publications dans "Bilirubine" :
3 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Publications dans "Bilirubine" :
3 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Neonatology Department, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin, Martin, Slovakia.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Neurology Clinic, Department of Medical, Surgical and Health Sciences, University of Trieste, 34139 Trieste, Italy.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Laboratory, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Laboratory, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Photonics Center, Skolkovo Institute of Science and Technology, Moscow, Russia.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Photonics Center, Skolkovo Institute of Science and Technology, Moscow, Russia.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Italian Liver Fondation, Bldg. Q-AREA Science Park Basovizza, SS14, km. 163,5, 34149 Trieste, Italy.
Publications dans "Bilirubine" :
2 publications dans cette catégorie
Affiliations :
Department of Hepatic Surgery and Liver transplantation Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Publications dans "Bilirubine" :
There is widespread consensus that adjuvant local use of antimicrobial agents in combination with their systemic administration can better prevent and treat implant-associated musculoskeletal infectio...
The aim of local application is to protect the foreign bodies directly at the implantation site from bacterial colonization and biofilm formation (prophylaxis) and to support the eradication of an alr...
In cases of infection, surgeons should ideally work together with microbiologists, infectiologists or clinical pharmacists to determine which anti-infective agents are indicated systemically for the p...
Processing properties of PMMA bone cements can be divided into four phases: 1. mixing, 2. waiting, 3. processing and 4. curing. Each of these phases is subject to several external influencing factors,...
PMMA-based bone cements are used for anchoring artificial joints. The cements are offered as two-component systems. During mixing, a liquid paste is formed by free-radical polymerization, which comple...
Bone cement implantation syndrome (BCIS) is a potentially serious complication after joint replacement surgery, resulting from bone marrow debris and cement embolisation, culminating in pulmonary and ...
Polymethylmethacrylate (PMMA) bone cement is used in orthopedics and dentistry to get primary fixation to bone but doesn't provide a mechanically and biologically stable bone interface. Therefore, the...
The purpose of the study is to assess the compressive strength, flexural strength, maximum temperature, and setting time of traditional PMMA bone cements that have been manually blended with 7 wt% HNT...
PMMA powder and monomer liquid were combined to create the control group, the reinforced group was made by mixing the PMMA powder with 7 wt% HNT fillers before liquid mixing. Chemical characterization...
The findings demonstrated that the novel reinforced PMMA-based bone cement with 7 wt% HNT fillers showed higher mean compressive strength values (93 MPa) and higher flexural strength (72 MPa). and low...
The novel PMMA-based bone cement with the addition of 7 wt% HNTs can effectively be used in orthopedic and dental applications, as they have the potential to enhance the compressive and flexural stren...
To verify the clinical significance of the best puncture-side bone cement/vertebral volume ratio (PSBCV/VV%) and bone cement leakage in paravertebral veins during vertebroplasty....
This was a retrospective analysis of a total of 210 patients from September 2021 to December 2022, who were divided into an observation group (110 patients) and a control group (100 patients). In the ...
There were no statistically significant differences (P > 0.05) in the evaluated indicators between the two groups pre- or postoperatively, including the anterior vertebral margin height, mid-vertebral...
In vertebroplasty, preoperative VV calculations using Mimics software, combined with calculation of the PSBCV according to the best PSBCV/VV% (13.68%), can effectively prevent leakage of bone cement i...
Bone regeneration is a rapidly growing field that seeks to develop new biomaterials to regenerate bone defects. Conventional bone graft materials have limitations, such as limited availability, compli...
The aim of this study was to investigate the effects of adding hexagonal boron nitride at four different concentrations to polymethylmethacrylate (PMMA) bone cement, which is commonly used in orthoped...
The study included an unaltered control group and groups containing four different concentrations (40 g of bone cement with 0.5 g, 1 g, 1.5 g, 2 g) of hexagonal boron nitride. The samples used for mec...
The samples with 0.5 g boron added to the bone cement had significantly increased mechanical strength, particularly in the compression test. In the group where 2 g boron was added, it was noted that, ...
Our study results demonstrate that adding hexagonal boron nitride (HBN) to bone cement at a low concentration (0.5 g / 40 g PPMA) significantly increases the mechanical strength in terms of MPa (compr...
The aim of this study was to evaluate treatment efficacy of percutaneous injection of hydroxyapatite-osteoconductive-cement in patients with spinal aneurysmal bone cysts....
The study was designed as a retrospective observational clinical study. We included patients who were diagnosed with of spinal aneurysmal bone cyst, at our institution between 2013 and 2020, and treat...
Our study included nine patients, two children and seven adults. Three different types of approaches were applied: (single pedicle approach in 3 patients; double pedicle approach in 2 patients; while ...
Treatment of symptomatic spinal ABC's with hydroxyapatite cement is effective to achieve complete pain reduction and sclerosis....
The timing for resuming continuous positive airway pressure (CPAP) postoperatively after skull base surgery remains controversial because of the risk of pneumocephalus. We determined the safety of imm...
Prospective cohort study....
Tertiary academic medical center....
Thirteen consecutive patients with CPAP-treated obstructive sleep apnea and temporal bone sCSF leaks who underwent skull base repair with hydroxyapatite bone cement between July 2021 and October 2022....
CPAP use resumed on postoperative day 1 after the confirmation of skull base reconstruction with temporal bone computed tomography (CT)....
Postoperative skull base defects on CT, pneumocephalus, or intracranial complications....
The average age was 55.5 ± 8.8 years (±standard deviation), and 69.2% were female with a BMI of 45.39 ± 15.1 kg/m 2 . Multiple tegmen defects were identified intraoperatively in 53.9% of patients with...
Immediate postoperative CPAP use is safe in patients undergoing MCF sCSF leak repair with bone cement because of the robust skull base repair....